Patients were randomized to inhalation of tobramycin ( @ mg/@ mL ) or placebo ( @ mL isotonic saline ) once daily ( @ minutes/nostril ) with the PARI Sinus nebulizer over @ days , with all patients eligible for a subsequent course of open-label inhalation of tobramycin for @ days .